Welcome to the Laboratory of Dr. Tim Miller, MD, PhD
ANNOUNCEMENT: The FDA has approved Radicava (edaravone) to treat patients with ALS. Learn more here!
ABOUT OUR RESEARCH CURRENT CLINICAL TRIALS
The Miller Laboratory is dedicated to understanding neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and dementias in order to develop new, effective, and safe treatments. Part of the Department of Neurology at Washington University School of Medicine in St. Louis, the Miller Laboratory is headed by Dr. Timothy M. Miller, MD, PhD, the David Clayson Professor of Neurology. Dr. Miller is a national leader in translational neuroscience and new therapeutic approaches for neurodegenerative diseases.